C. Kaehler (Innsbruck, Austria), M. Koenigshoff (Munich, Germany)
LATE-BREAKING ABSTRACT: FGF10 identifies early lipofibroblast progenitors and controls their fate during embryonic lung development
D. Al Alam, E. El Agha, S. Danopoulos, V. Rehan, S. Bellusci (Los Angeles, United States Of America; Giessen, Germany)
|  |
LSC 2013 abstract - Bioavailability of VEGF in idiopathic pulmonary fibrosis
S. Barratt, C. Jarrett, T. Blythe, K. Ourradi, G. Welsh, D. Bates, A. Millar (Bristol, United Kingdom)
| |
A functional role for WNT-5A in driving airway myocyte proliferation
T. Koopmans, K. Kumawat, M. Van den Berge, H. Meurs, R. Gosens (Groningen, Netherlands)
|  |
LSC 2013 abstract - Unravelling VEGF165 signalling in the lung
K. Ourradi, T. Blythe, S. Barratt, C. Jarett, G. Welsh, A. Millar (Bristol, United Kingdom)
| |
LSC 2013 abstract - Mechanisms regulating enhanced alphavbeta6 expression in pulmonary fibrosis
A. Tatler, A. Goodwin, O. Gbolohan, R. Clifford, P. Weinreb, S. Violette, M. Kolb, J. Gauldie, P. Wolters, A. Knox, G. Jenkins (Nottingham, United Kingdom; Cambridge, San Francisco, United States Of America; Hamilton, Canada)
| |
A possible therapeutic agent for pulmonary fibrosis: Antibody against integrin alpha8beta1
N. Nishimichi, K. Kanno, K. Sentani, W. Yasui, Y. Yokosaki (Hiroshima, Japan)
| |
Proteasome function in lung fibrosis
N. Pfister, O. Eickelberg, S. Meiners (Munich, Germany)
| |
Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS)
A. Buchbinder, J. Ott, A. Mohr, W. Seeger, K. Mayer (Giessen, Germany)
| |
PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis
T. Suzuki, M. Suzuki, G. Downey, K. Hagiwara (Iruma-gun, Japan; Denver, United States Of America)
| |
Serine and arginine-rich splicing factors as nuclear targets for TGF-beta1
O. Hallgren, J. Malmström, L. Malmström, A. Andersson-Sjöland, M. Wildt, E. Tufvesson, G. Marko-Varga, G. Westergren-Thorsson (Lund, Sweden; Zurich, Lund, Switzerland)
| |
Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway
C. H. Lin, C. M. Weng, B. C. Chen, M. L. Kuo (Taipei, Taiwan)
| |
Differential VEGF signalling in the lung
K. Ourradi, T. Blythe, C. Jarrett, S. Barratt, G. Welsh, A. Millar (Bristol, United Kingdom)
| |
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
H. Tawel, W. Coward, K. Deacon, L. Pang (Nottingham, United Kingdom)
| |
WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells
H. Baarsma, M. Königshoff (München, Germany)
| |
Cigarette smoke extract and TGF-beta1 induce distinctive expression of extracellular matrix protein genes in human airway smooth muscle cells
L. Chen, Q. Ge, J. Black, J. Burgess, B. Oliver (Sydney, Australia; Chongqing, China)
| |
Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene
D. Lopes, V. Martins, W. Teodoro, E. R. Parra, V. L. Capelozzi (São Paulo, Brazil)
| |
Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
R. Mahida, D. Bartis, D. Thickett (Birmingham, United Kingdom)
| |
Deletion of peroxiredoxin 6 potentiates OVA-induced asthma epithelial-mesenchymal transition through EGFR pathway
D. Yang, Y. Mou, C. Dong, M. Jin, C. Bai (Shanghai, China)
| |